Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-23-021525

Chief Executive Officer bought 10,000 shares at $0.49 ($4,900)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huntsman Ronald Kirk Chief Executive Officer 2023-06-14 Purchase +10,000 $0.49 $4,900 57,500 D
Open-market purchases · 10,000 sh · avg $0.49 · $4,900
Loading xslF345X04/ownership.xml…